Avalere Health
An Inovalon Company

Federal & State Healthcare Policy

Predict Change

As the nation continues to struggle with improving outcomes, elevating quality, reducing costs, and driving value, federal and state policy activities remain core to making sound decisions for your business. Armed with policy experts and business strategists, Avalere guides organizations through the continued complexities of all aspects of healthcare public policy at both the federal and state levels. We help companies understand how changes to healthcare policy will affect coverage, access, payment, care delivery, and consumer choice. We partner with stakeholders from across the healthcare spectrum to help plan for insurance market reforms, Medicaid, Medicare Advantage, and Medicare Part D changes.

What's Your Challenge?

  • ​Policy Impact and Analysis
  • ​Policy Tracking and Monitoring
  • ​Comment Letters
  • ​Beneficiary Enrollment Trends

Complementary Products


Meet a few of our experts ready to partner with you.

All Staff

Elizabeth Carpenter

Senior Vice President


Elizabeth Carpenter, Senior Vice President, leads the Policy Practice at Avalere. Specifically, Elizabeth focuses on implementation of the Affordable Care Act, trends in commercial insurance, drug pricing policy, and the impact of politics on the policy landscape. 

Prior to joining Avalere, Elizabeth was a Senior Advisor in the Health Policy practice at McKenna Long & Aldridge LLP and the Associate Policy Director for the Health Policy Program at the New America Foundation. Previously, she served on both the legislative and campaign staffs of Senator Lincoln Chafee (RI).

Elizabeth has a BA in Political Science from Brown University.

Brenda Huneycutt

Vice President


Brenda Huneycutt, PhD, JD, MPH, Vice President in Avalere’s FDA Strategy and Regulatory Policy practice, advises clients on regulatory strategy and policy spanning drugs, biologics, and diagnostics and conducts due diligence assessments for clients looking to acquire or in-license products. Using her molecular biology research background, combined with her legal and public health policy training, Brenda helps clients translate technical information into clear descriptions for various audiences and offers special expertise in regulatory strategy for FDA approval strategies involving accelerated and new pathways, including breakthrough therapy and orphan designations, biosimilars, and interchangeable biologics. 

Prior to joining Avalere, Brenda conducted research at the Genetics and Public Policy Center at Johns Hopkins University and was a Patent Attorney for Finnegan, LLP.

Brenda has a PhD in Molecular, Cellular, and Developmental Biology from the University of Colorado at Boulder, a JD from the George Washington University School of Law, an MPH from Johns Hopkins Bloomberg School of Public Health, and a BA in Biology from the University of Delaware.

Lisa Hunter

Senior Manager


Lisa Hunter, Senior Manager, supports health plan and delivery system clients by developing practical strategies to market challenges and leveraging Avalere’s deep substantive expertise driven by rigorous quantitative and qualitative research. Lisa draws on her government programs expertise, federal policy experience, and project management and leadership skills to help clients assess and improve business strategies and operations. In addition to providing direct client support, Lisa also helps drive growth and business development for the health plan and provider practices.

Prior to joining Avalere, Lisa served in the Immediate Office of the Secretary and in the Office of the Assistant Secretary for Legislation at the U.S. Department of Health and Human Services (HHS), where she supported the Affordable Care Act (ACA) implementation and other federal priorities.  Before her political appointment, Lisa spent time on Capitol Hill serving in the offices of Congresswoman Judy Chu and Congressman Howard Berman.

Lisa earned an MPP from Georgetown University and BA in Anthropology from Vassar College.  

Daniel Goldberg



Daniel Goldberg, Manager, provides research and strategic support to health plan and life sciences clients on health reform implementation and state health policy activities. In particular, he applies his expertise on policy issues related to commercial market benefit design, insurance exchanges, Medicaid managed care, and dual-eligible beneficiaries. 

Prior to joining Avalere, Daniel interned on the U.S. Senate Committee on Health, Education, Labor and Pensions, providing research and legislative initiative support to Senator Harkin’s health policy team. In this role, he authored memos on congressional briefings and hearings related to health policy. He also conducted research services for the Office of the Inspector General of the U.S. Department of Health and Human Services, Memorial Hermann Hospital, and MedStar Georgetown University Hospital. 

Daniel has a BS in Healthcare Management and Policy and a minor in Health Promotion and Disease Prevention from Georgetown University.  

« Back to Mobile Site